Satipharm AG
Country: Switzerland
Satipharm is a pharmaceutical-grade CBD company specializing in advanced cannabinoid delivery systems, with a focus on clinically validated formulations. Headquartered in Switzerland and operating under parent company Cann Group Limited (Australia), Satipharm is best known for its patented GelpellĀ® capsule technology, which enhances the bioavailability and consistency of oral CBD products. The company targets both the medical and wellness sectors, providing precise, reliable dosing backed by clinical research.
Satipharmās products are manufactured to GMP standards and are used in both therapeutic and over-the-counter settings. With a strong focus on product efficacy, regulatory compliance, and patient safety, Satipharm serves healthcare providers, pharmacies, and wellness distributors across Europe, Australia, and other international markets.
Alt contact: š Phone: +41 (0)43 508 14 71
āļø Email: info@satipharm.com
Website: https://www.satipharm.com
Phone: (41) 799 647 542
Key Contact: Stanislav Sologubov
Email: Click to email
Street Address: Lƶwenstrasse 3
City: ZĆ¼rich
State/Region: ZĆ¼rich
Postal Code: 8001
Country: Switzerland
Claim Your Listing
You're one step away from taking control. If this is your company, claim the listing now to update your profile, add contact details, showcase your offerings, and make it easier for customers and partners to find you.
